ARTICLE | Company News
FDA approves Boehringer's Pradaxa
October 20, 2010 12:52 AM UTC
FDA approved an NDA from Boehringer Ingelheim GmbH (Ingelheim, Germany) for Pradaxa dabigatran to prevent stroke and blood clots in patients with abnormal heart rhythm (atrial fibrillation). The compa...